Chinese online-to-offline (O2O) medicine retailer Dingdang Kuaiyao has raised RMB600 million ($89 million) in a Series C round of funding led by existing investor Softbank China Venture Capital, according to an announcement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
